A method for preventing AMR in a human kidney transplant recipient is provided. The method comprises: selecting a deceased donor selecting a kidney transplant recipient transplanting the kidney from the donor to the recipient and administering a therapeutically effective dose of an anti-C5 antibody or fragement thereof to the recipient. The recipient is generally sensitized to the donor. Also provided is a method for treating AMR in a kidney transplant patient. The method comprises: selecting a kidney transplant patient having symptoms of AMR and administering a therapeutically effective dose of an anti¬ cs antibody or fragment thereof to the patient wherein the dose of the anti-C5 antibody or fragment thereof reduces the symptoms of AMR.
